Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report

Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report

Abstract Background Biologics dramatically improve symptoms of severe asthma; however, various exacerbating factors may induce flare-up. Pneumocystis spp. have not been reported as a cause of asthma exacerbation during biologic use, although patients with severe asthma have high levels of antibodies...

Full description

Bibliographic Details
Main Authors: Kazuya Takeda, Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Hiroki Watanabe, Yuichi Yamada, Hirofumi Chiba
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Severe bronchial asthma
Mepolizumab
Pneumocystis pneumonia
Pneumocystis jirovecii
Online Access:https://doi.org/10.1186/s13223-022-00678-y

Internet

https://doi.org/10.1186/s13223-022-00678-y

Similar Items